CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• F. Cash Flow Y/Y Annual
Genmark Diagnostics Inc   (GNMK)
Other Ticker:  
 
 

GNMK's Free Cash Flow Growth by Quarter and Year

Genmark Diagnostics Inc 's Free Cash Flow results by quarter and year




GNMK Free Cash Flow (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December -0.54 -9.36 -3.61 -12.82
III Quarter September 6.29 -9.96 -12.46 -12.44
II Quarter June 7.99 -7.44 -10.39 -12.60
I Quarter March -7.61 -8.18 -6.05 -15.57
FY   6.13 -34.94 -32.51 -53.43



GNMK Free Cash Flow fourth quarter 2020 Y/Y Growth Comment
Genmark Diagnostics Inc in the fourth quarter 2020 recorded free cash outflow of $ -0.54 millions.

Looking into fourth quarter 2020 results within Medical Equipment & Supplies industry 2 other companies have achieved higher Free Cash Flow growth. While Genmark Diagnostics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. 53 in the fourth quarter 2020.


GNMK Free Cash Flow ( Y/Y Growth %) 2020
 2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Genmark Diagnostics Inc 's fourth quarter 2020 Free Cash Flow $ -0.54 millions GNMK's Income Statement
Genmark Diagnostics Inc 's fourth quarter 2019 Free Cash Flow $ -9.36 millions Quarterly GNMK's Income Statement
New: More GNMK's historic Free Cash Flow Growth >>


GNMK Free Cash Flow (Quarter on Quarter Growth %)

 2020
 2019 2018 2017
IV Quarter December - - - -
III Quarter September -21.28 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -


See the full GNMK Cash flow Statement >> Back to GNMK Growth rate Comparisons >>


Free Cash Flow fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #7
Overall #53

Free Cash Flow Y/Y Growth Statistics
High Average Low
292.68 % 292.68 % 292.68 %
(Dec 31 2020)  
Free Cash Flow fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #7
Overall #53
Free Cash Flow Y/Y Growth Statistics
High Average Low
292.68 % 292.68 % 292.68 %
(Dec 31 2020)  

Free Cash Flow by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Genmark Diagnostics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GNMK's IV. Quarter Q/Q Free Cash Flow Comment
IV. Quarter 2020 accomplishment of -0.54 millions by Genmark Diagnostics Inc come out even less good if you take a look at 6.29 millions in the previous quarter.

Within Medical Equipment & Supplies industry Genmark Diagnostics Inc achieved highest sequential Free Cash Flow growth. While Genmark Diagnostics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GNMK's IV. Quarter Q/Q Free Cash Flow Comment
IV. Quarter 2020 results of -0.54 millions by Genmark Diagnostics Inc come out even less good considering the 6.29 millions in the third quarter.

Within Medical Equipment & Supplies industry Genmark Diagnostics Inc achieved highest sequential Free Cash Flow growth. While Genmark Diagnostics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Genmark Diagnostics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)		 12 Months Ending
(Mar 31 2020)		 12 Months Ending
(Dec 31 2019)
Cumulative Free Cash Flow 12 Months Ending $ 23.91 $ 6.09 $ -15.60 $ -31.64 $ -32.83
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) 292.68 % - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 145 # 34 # 52 # 0 # 0

New: More GNMK's historic Free Cash Flow Growth >>



Cumulative Free Cash Flow growth Comment
In the Dec 31 2020 period, Genmark Diagnostics Inc had cumulative twelve months Free Cash Flow of $ 24 millions compare to free cash outflow of $ -33 millions a year ago.
Not only that Genmark Diagnostics Inc has restored the prosperity, the company is already gaining momentum and showing above usual Free Cash Flow gain, from the period from Sep 30 2020 to Dec 31 2019 of 292.68 % from $6.09 millions.

Genmark Diagnostics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 16
S&P 500 # 145
Cumulative Free Cash Flow growth Comment
In the Dec 31 2020 period, Genmark Diagnostics Inc had cumulative twelve months Free Cash Flow of $ 24 millions compare to free cash outflow of $ -33 millions a year ago.
Even more so, not just that GNMK has restored the bottom-line, Genmark Diagnostics Inc is already improving fast and showing higher than normal Free Cash Flow rise, from the twelve months ending in the quarter before of 292.68 % from $6.09 millions.

Genmark Diagnostics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 16
S&P 500 # 145




Other Free Cash Flow Growth
Medical Equipment & Supplies Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
GNMK's Free Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for GNMK's Competitors
Free Cash Flow Growth for Genmark Diagnostics Inc 's Suppliers
Free Cash Flow Growth for GNMK's Customers

You may also want to know
GNMK's Annual Growth Rates GNMK's Profitability Ratios GNMK's Asset Turnover Ratio GNMK's Dividend Growth
GNMK's Roe GNMK's Valuation Ratios GNMK's Financial Strength Ratios GNMK's Dividend Payout Ratio
GNMK's Roa GNMK's Inventory Turnover Ratio GNMK's Growth Rates GNMK's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2020
Cumberland Pharmaceuticals Inc-0.36%$ -0.359 millions
Mallinckrodt Plc-2.20%$ -2.203 millions
Nuvasive Inc-2.67%$ -2.666 millions
Boston Scientific Corporation-2.75%$ -2.746 millions
Fonar Corporation-2.93%$ -2.927 millions
Ufp Technologies Inc -6.15%$ -6.152 millions
Eli Lilly And Company-7.56%$ -7.562 millions
Integra Lifesciences Holdings Corp-10.00%$ -10.004 millions
Abiomed Inc -11.52%$ -11.522 millions
American Shared Hospital Services-12.08%$ -12.083 millions
Amedisys Inc -12.37%$ -12.374 millions
Neurocrine Biosciences Inc -13.31%$ -13.313 millions
Tenet Healthcare Corp-14.23%$ -14.231 millions
Amgen Inc -14.36%$ -14.360 millions
Pra Health Sciences Inc -14.66%$ -14.659 millions
Prestige Consumer Healthcare Inc -15.12%$ -15.123 millions
Repligen Corp-15.86%$ -15.859 millions
Taro Pharmaceutical Industries Ltd-16.10%$ -16.096 millions
Phibro Animal Health Corporation-16.14%$ -16.135 millions
Haemonetics Corporation-16.39%$ -16.386 millions
Merck and Co Inc -16.44%$ -16.437 millions
Brookdale Senior Living Inc -16.56%$ -16.556 millions
Mei Pharma Inc -16.74%$ -16.735 millions
Crh Medical Corporation-17.84%$ -17.838 millions
Incyte Corporation-18.46%$ -18.460 millions
Adapthealth Corp -19.04%$ -19.045 millions
Tandem Diabetes Care Inc -21.63%$ -21.628 millions
Viemed Healthcare Inc -21.74%$ -21.743 millions
National Healthcare Corp-23.24%$ -23.236 millions
Global Cord Blood Corp-25.34%$ -25.338 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com